A case with psoriasis-like lesions induced by olmutinib (HM61713) while treating epidermal growth factor receptor T790M mutant advanced lung adenocarcinoma

Olmutinib (HM61713) is a third-generation tyrosine kinase inhibitor active against mutant EGFR, including T790M in nonsmall cell lung cancer. The most common side effect of olmutinib to date includes diarrhea, rash, nausea, and pruritus. To the best of our knowledge, it is the first case of psoriasi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chu-Ju Hung (Autore), Po-Ju Lai (Autore), Jen-Jung Cheng (Autore), Shiow-Jiuan Wey (Autore), Yu-Ping Hsiao (Autore), Ming-Fang Wu (Autore)
Natura: Libro
Pubblicazione: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

Connect to this object online.

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile